Fortuna Silver Mines
FSM
10.12
-1.06
-9.48%
Fortuna Silver Mines
US · FSM
#2421 by market cap
Listed 1970
10.12
-1.06
-9.48%
Live - 5344 symbols - heartbeat 547s ago
· 2026-10-08 08:22
Pre-market
10.07
-0.49%
After-hours
10.34
+2.17%
- Market cap
- 3.00B
- P/E (TTM)i
- 8.58
- P/Bi
- 1.70
- EPSi
- 0.90
- Div yieldi
- 0.00%
- 52W posi
- 39%
Reader sentiment
Are you bullish or bearish on FSM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.34, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +39.84% YoY
Margins
- Gross margin
- 49.30%
- Operating margin
- 38.98%
- Net margin
- 30.35%
Key ratios & quality
- Enterprise valuei
- 2.59B
- Altman Z-Scorei
- 4.34
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 263.30M | 257.19M | 278.97M | 599.85M | 681.49M | 842.43M | 677.24M | 947.06M |
| Gross profit | 96.57M | 84.58M | 110.22M | 205.48M | 146.80M | 190.03M | 233.36M | 466.90M |
| Selling & admin expenses | 26.19M | 29.81M | 35.09M | 45.36M | 61.46M | 66.87M | 68.09M | 97.74M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 68.95M | 52.08M | 73.46M | 141.52M | 82.98M | 119.65M | 165.27M | 369.16M |
| Pretax profit | 67.34M | 43.97M | 58.96M | 107.18M | -125.11M | -11.05M | 141.73M | 400.18M |
| Tax | 33.35M | 20.18M | 37.40M | 47.78M | 10.80M | 32.58M | 51.42M | 111.40M |
| Net profit | 33.99M | 23.80M | 21.55M | 59.40M | -135.91M | -43.63M | 141.91M | 311.06M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.21 | 0.14 | 0.12 | 0.23 | -0.44 | -0.17 | 0.41 | 0.90 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 195.04M | 230.42M | 251.36M | 270.24M | 342.47M | 318.41M |
| Gross profit | 80.34M | 105.03M | 133.13M | 148.40M | 211.84M | 183.46M |
| Selling & admin expenses | 23.90M | 21.58M | 26.30M | 25.96M | 27.79M | 18.67M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 55.75M | 83.40M | 109.22M | 120.79M | 182.18M | 163.19M |
| Pretax profit | 54.27M | 81.36M | 153.02M | 111.53M | 178.32M | 154.78M |
| Tax | 15.39M | 33.65M | 24.82M | 37.54M | 58.37M | 71.03M |
| Net profit | 64.81M | 44.07M | 128.20M | 73.99M | 119.95M | 83.75M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.19 | 0.12 | 0.38 | 0.19 | 0.35 | 0.24 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 218.92M | 152.64M | 248.07M | 281.08M | 252.71M | 333.33M | 486.24M | 764.53M |
| Cash & ST investments | 163.33M | 83.40M | 132.96M | 107.51M | 80.49M | 128.15M | 231.39M | 560.75M |
| Inventory | 14.39M | 14.97M | 35.27M | 85.82M | 92.03M | 115.83M | 134.50M | 122.69M |
| Total assets | 786.52M | 936.07M | 1.06B | 2.02B | 1.88B | 1.97B | 2.12B | 2.36B |
| Total current liabilities | 61.33M | 89.77M | 96.44M | 166.77M | 135.08M | 243.77M | 256.03M | 256.38M |
| Short-term debt | 3.40M | 8.83M | 6.98M | 10.52M | 9.42M | 58.84M | 19.76M | 21.20M |
| Long-term debt | 69.30M | 146.54M | 158.62M | 157.49M | 219.18M | 162.95M | 126.03M | 134.41M |
| Total liabilities | 183,713,000.00 | 300,639,000.00 | 329,568,000.00 | 592,352,000.00 | 587,528,000.00 | 679,742,000.00 | 649,459,000.00 | 625,323,000.00 |
| Total equity | 602.80M | 635.43M | 725.77M | 1.43B | 1.29B | 1.29B | 1.47B | 1.74B |
| Retained earnings | 163.39M | 187.19M | 208.74M | 266.62M | 138.49M | 87.65M | 216.38M | 488.13M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 577.40M | 587.52M | 646.96M | 764.53M | 891.91M | 835.46M |
| Cash & ST investments | 309.40M | 394.02M | 444.18M | 560.75M | 675.82M | 614.39M |
| Inventory | 135.91M | 120.41M | 110.74M | 122.69M | 121.06M | 138.87M |
| Total assets | 2.19B | 2.14B | 2.24B | 2.36B | 2.49B | 2.50B |
| Total current liabilities | 283.24M | 216.97M | 196.18M | 256.38M | 281.13M | 278.20M |
| Short-term debt | 20.53M | 22.10M | 21.39M | 21.20M | 21.46M | 30.81M |
| Long-term debt | 127.99M | 130.04M | 132.19M | 134.41M | 136.60M | 138.91M |
| Total liabilities | 657,838,000.00 | 595,868,000.00 | 569,644,000.00 | 625,323,000.00 | 652,340,000.00 | 678,355,000.00 |
| Total equity | 1.53B | 1.54B | 1.67B | 1.74B | 1.84B | 1.82B |
| Retained earnings | 274.89M | 304.93M | 428.52M | 488.13M | 586.88M | 612.73M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 83.46M | 60.15M | 93.39M | 147.14M | 194.25M | 296.91M | 235.70M | 455.37M |
| Depreciation & amortization | 44.77M | 46.35M | 45.41M | 122.27M | 172.81M | 219.69M | 175.52M | 191.02M |
| Free cash flow | -14.44M | -161.13M | 352.00K | -5.15M | -56.99M | 79.60M | 74.62M | 277.36M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 959.00K | 0 | 70.01M | 313.00K | -5.93M | 0 | -34.13M | -10.27M |
| Ending cash balance | 90.50M | 83.40M | 131.90M | 107.10M | 80.49M | 128.15M | 231.33M | 553.99M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 176.75M | 67.31M | 111.35M | 150.34M | 418.88M | 138.28M |
| Depreciation & amortization | 44.79M | 48.34M | 53.04M | 44.85M | 45.91M | 44.02M |
| Free cash flow | 138.79M | 20.29M | 62.80M | 105.85M | 373.60M | 70.40M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -4.17M | 0 | 0 | -6.10M | -24.45M | -82.13M |
| Ending cash balance | 308.11M | 378.42M | 438.28M | 553.99M | 665.91M | 606.67M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.83 | 3.84 | 3.17 | 5.51 | -9.78 | -4.09 | 9.74 | 18.66 |
| ROA %i | 4.55 | 2.76 | 2.16 | 3.76 | -6.57 | -2.64 | 6.31 | 12.84 |
| ROIC %i | 5.12 | 3.16 | 2.61 | 5.42 | -7.95 | -2.49 | 9.36 | 16.96 |
| 5-year avg ROE %i | 5.30 | 4.87 | 6.29 | 6.36 | 1.71 | -0.27 | 0.91 | 4.01 |
| EBIT margin %i | 26.31 | 17.66 | 21.94 | 20.21 | -16.69 | 1.32 | 22.72 | 44.99 |
| FCF / sales %i | -- | -- | -- | -- | -- | 9.45 | 15.24 | 29.29 |
| Current ratioi | 3.57 | 1.70 | 2.57 | 1.69 | 1.87 | 1.37 | 1.90 | 2.98 |
| Quick ratioi | 3.20 | 1.49 | 2.17 | 1.11 | 1.11 | 0.83 | 1.31 | 2.48 |
| Debt / assetsi | 9.93 | 18.21 | 16.88 | 9.24 | 12.82 | 13.43 | 9.17 | 8.95 |
| LT debt / equityi | 12.39 | 25.43 | 23.58 | 12.83 | 18.57 | 16.59 | 12.41 | 11.34 |
| Interest coveragei | 36.04 | 31.39 | 27.07 | 8.63 | -10.02 | 0.50 | 8.31 | 16.46 |
| Revenue CAGR (3Y) %i | 19.39 | 6.95 | 1.33 | 31.58 | 38.38 | 44.54 | 4.13 | 11.59 |
| Net income CAGR (3Y) %i | -- | 10.04 | -31.24 | 19.41 | -- | -- | 30.54 | -- |
| FCF CAGR (3Y) %i | -- | -- | -75.02 | -- | -- | 509.23 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.83 | 11.14 | 15.18 | 18.66 | 21.03 | 23.19 |
| ROA %i | 7.79 | 7.57 | 10.67 | 12.84 | 14.53 | 16.32 |
| ROIC %i | 11.15 | 10.38 | 13.97 | 16.96 | 19.08 | 20.71 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 24.74 | 27.23 | 33.94 | 44.99 | 50.31 | 52.80 |
| FCF / sales %i | 20.94 | 18.17 | 18.11 | 29.29 | 46.80 | 34.09 |
| Current ratioi | 2.04 | 2.71 | 3.30 | 2.98 | 3.17 | 3.00 |
| Quick ratioi | 1.43 | 2.13 | 2.69 | 2.48 | 2.66 | 2.44 |
| Debt / assetsi | 9.05 | 10.10 | 9.52 | 8.95 | 8.40 | 9.38 |
| LT debt / equityi | 12.14 | 12.98 | 11.86 | 11.34 | 10.60 | 11.51 |
| Interest coveragei | 10.43 | 11.58 | 16.34 | 16.46 | 20.82 | 23.32 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Sango is the largest reported line at 58.33% of revenue, across 3 reported segments.
- Mansfield follows at 28.35%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Sango58.33%
Mansfield28.35%
Bateas13.33%
Quote time 2026-10-08 08:22:07 · For reference only, not investment advice and not tailored to your situation.